Auditory nerve fibers' (ANFs) refractoriness and facilitation can be quantified in electrically evoked compound action potentials (ECAPs) recorded via neural response telemetry (NRT). Although facilitation has been observed in animals and human cochlear implant (CI) recipients, no study has modeled this in human CI users until now. In this study, recovery and facilitation effects at different masker and probe levels for three test electrodes (E6, E12 and E18) in 11 CI subjects were recorded. The ECAP recovery and facilitation were modeled by decaying exponential functions and the same function used for +10 CL masker offset condition can be applied to all other masker offsets measurements. Goodness of fit was evaluated for the decaying exponential functions. A significant effect of probe level was observed on a recovery time constant which highlights the importance of recording the recovery function at the maximum acceptable stimulus level. Facilitation time constant and amplitude showed no dependency on the probe level. However, facilitation was stronger for masker level at or around the threshold of the ECAP (T-ECAP). There was a positive correlation between facilitation magnitude and amplitude growth function (AGF) slope, which indicates that CI subjects with better peripheral neural survival have stronger facilitation.
Introduction
Intracochlear recording of the electrically evoked compound action potential (ECAP) from the auditory nerve fibers (ANFs) with Nucleus ® cochlear implants (CIs) is possible via neural response telemetry (NRT). The NRT system applies an electrical pulse on a given electrode and the evoked neural response is recorded at a neighboring electrode (Dees et al., 2005; Botros et al., 2007) . The ECAP represents a synchronized response from electrically stimulated ANFs and recorded as a negative peak (N1) followed by a smaller positive peak (P1) (Brown et al., 1998; Abbas et al., 1999; Lai and Dillier, 2000) . In comparison to other electrophysiological measures such as the electrically evoked auditory brainstem response (EABR) which would require extra recording electrodes, dedicated software and additional measuring equipment, the ECAP measurement only involves the clinical software provided by the manufacturer. ECAPs can be recorded directly from the intracochlear electrodes positioned close to the auditory nerves. The measurement is fast and requires minimal patient cooperation (Lai and Dillier, 2000; Miller et al., 2000; Shpak et al., 2004; Hughes, 2006; He et al., 2017) .
The NRT system has the ability to measure temporal response properties of ANFs such as the refractory recovery function and the facilitation (temporal summation) effect. In these measurements, a two-pulse (masker-probe) paradigm is used and the neural response to the second pulse (the probe) is measured as a function of the interpulse interval (Brown et al., 1990; Miller et al., 2000; Morsnowski et al., 2006; Botros and Psarros, 2010; Hey et al., 2017) . The masker-probe paradigm uses forward masking effects to eliminate the relatively large amplitude stimulus artifact that overlaps the neural response . Two widely used ECAP artifact cancellation methods are the standard forward masking technique (Brown et al., 1990 ) and the modified forward masking method by Miller et al. (2000) . It was shown that the forward masking technique is not very effective in canceling artifacts when the neural response is partially masked, which would be the case in recovery function measurement .
Neural refractoriness of the electrically stimulated ANFs is defined as a reduction in the excitability of the auditory nerve immediately following an action potential and has been investigated in clinical studies with CI recipients by measuring the ECAP recovery function Battmer et al., 2004; Shpak et al., 2004; Morsnowski et al., 2006; Cohen, 2009; Botros and Psarros, 2010; Kim et al., 2011; Lee et al., 2012) . The refractory period can be divided into an absolute refractory period (ARP) and a relative refractory period (RRP). During the ARP which lasts about 300-400 µs Morsnowski et al., 2006; Boulet et al., 2016) , the auditory nerve is incapable of responding to the probe stimulus. To induce a response during the RRP, a greater stimulus intensity is needed compared to the interval when the neuron is outside the refractory period (Bruce et al., 1999; Boulet et al., 2016) . In the modified forward M A N U S C R I P T
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masking method, the refractoriness from the masker leads to the masking of the probe, and when the masker probe interval (MPI) increases, the auditory nerve gradually recovers from the refractoriness caused by the masker Botros and Psarros, 2010; He et al., 2017) . Therefore, the firing probability of the neurons relative to the resting probability starts to increase from 0 and returns gradually to 1, which corresponds to full recovery.
It has been observed that the recovery time constant is dependent on stimulus level with faster recovery at higher levels (Battmer et al., 2004; Cohen, 2009; Botros and Psarros, 2010; He et al., 2017) . This is in contrast to what has been reported about the effect of stimulus level on recovery time constant in other studies in which tested stimulus levels were selected about subjective uncomfortable levels (Brown et al., 1990; Lai and Dillier, 2010) . Brown et al. (1990) observed that differences in probe level do not influence the form of recovery function, and Lai and Dillier (2010) found large variations in the recovery time constant only at lower ECAP response amplitudes (<100 µV). Therefore, the first aim of this study is to evaluate the effect of probe level on the recovery time constant and absolute refractory period. In addition to the probe level, the effect of masker level while the probe level is kept constant will be examined.
Electrical stimulation of ANFs in animals with pairs of pulses has shown facilitation, which is defined as an increase in nerve excitability caused by subthreshold stimulation in short intervals (Dynes, 1996; Cartee et al., 2000; Heffer et al., 2010; Boulet et al., 2016) . Apart from animal studies, the facilitation effect has also been observed in human CI recipients (Cohen, 2009; Karg et al., 2013; Hey et al., 2017) . As reviewed in Boulet et al. (2016) , a primary cause of facilitation is residual charge remaining on the neural membrane from the first pulse. A second, and connected, mechanism behind facilitation is sodium channel activation near threshold. When the membrane potential is near the threshold potential and the neuron does not produce an action potential, residual sodium activation can increase the excitability to the next pulse. But the sodium channel inactivation limits the duration over which facilitation can accumulate. If the membrane potential remains near the threshold long enough before sodium inactivation commences, the second pulse can produce a response. This leads to a higher probability of facilitation at shorter MPIs with the increase of magnitude by decreasing the MPIs (Dynes, 1996; Cartee et al., 2000) . A recent study by Hey et al. (2017) has shown that the facilitation is more evident at a low MPI and its maximum happens for a masker level at or below ECAP threshold.
As mentioned, previous studies have shown traces of facilitation in single ANF recordings or in ECAP measurements of human CI recipients. The effect of facilitation was observed or measured for MPIs up to 300 µs (Cartee et al., 2000 (Cartee et al., , 2006 Boulet et al., 2016; Hey et al., 2017) , however, other studies reported facilitation up to 2 ms (Dynes, 1996; Nelson and Donaldson, 2001; Cohen, 2009; Karg et al., 2013) . Thus, the second aim of this study is to model the facilitation effect and explore the effect of probe and masker levels on this phenomenon. This includes modeling of the facilitation effect with a decaying exponential function and defining the facilitation time constant based on ECAP recordings of human CI users who participated in this study.
Materials and methods
All procedures performed in this study were in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki). Ethics approvals from Swissmedic (2018-MD-0005) and Zürich ethics committee (2017-00600) were obtained before the start of the study. All subjects had signed informed consent forms.
Subject selection
Subjects for this study were recruited from experienced recipients of Nucleus ® cochlear implants (CI24RE(CA), CI422, CI512 or CI522). Subjects were considered for this study if they were in good health condition and had at least 20 active electrodes. Dizziness and any acute inflammation or pain in the head-neck area would exclude the subject from participation. 11 CI recipients (8 females, 3 males) aged between 23 and 69 years (mean age 51±15 years) volunteered to participate in this study. Participants had on average 76 months of experience with their CI, with the range from 16 to 148 months. The demographic details of the CI participants are presented in Table 1 .
[ 
Measurement parameters
Before the start of the measurements, subjective thresholds, the loudest acceptable presentation level (LAPL) and individual amplitude growth functions (AGFs), obtained using a forward masking subtraction paradigm Lai and Dillier, 2000) , were recorded for three test electrodes (E6, E12 and E18). The masker offset, defined as the current level (CL) of the masker relative to the probe, was set to +10 CL. The corresponding ECAP thresholds (T-ECAPs), also sometimes known as T-NRTs, were determined by the extrapolation of the AGFs (Botros et al., 2007) . Clear ECAP responses could not be captured for electrode E18 of subject S6 and electrode E12 of subject S10; consequently, electrodes E20 and E13 were measured instead for these two subjects respectively.
Biphasic pulses with 25 µs pulse width and 7 µs interphase gap were used except for subject S10, with whom the ECAP responses could be obtained only with 37 µs pulse width for three test electrodes. The modified forward masking method by Miller et al. (2000) was used for the subsequent measurements. This method typically involves a pair of measurements, one at the desired MPI, followed by another at the reference MPI. Note that the reference MPI measurement is repeated throughout a series of measurements using this method at different MPIs. The clinical Custom Sound EP (CSEP) software (Patrick et al., 2006) allows these measurement pairs to be recorded separately as so-called 'BC recording'. The reference 'BC recording' used a +10 CL masker offset and an MPI of 300 µs as suggested by Morsnowski et al. (2006) . Subtracting the reference 'BC recording' from the non-reference counterpart, which was performed offline afterwards, yields the desired ECAP response. This reduces the time of measurement to approximately half, making the recordings less tiring for the participants.
Since in the ECAP recordings facilitation and absolute refractoriness overlap (Hey et al., 2017; Cohen, 2009) , in this study these two phenomena were recorded together in the same series of measurement. When the MPI is short, the facilitation effect is dominant and by increasing the MPI some neurons start to move from absolute to relative refractoriness until they are fully recovered. Therefore, the MPIs varied from 13 µs (the shortest MPI possible with the clinical CSEP software v.5.0) to 6000 µs which would be long enough to obtain the recovery function (Morsnowski et al., 2006; Cohen, 2009) . Facilitation and recovery functions were measured with 14 MPIs applying the 'BC recording' method (MPI = 13, 50, 80, 100, 150, 200, 300, 350, 400, 600, 1000 (MPI = 13, 50, 80, 100, 150, 200, 300, 350, 400, 600, , 2000 , 6000 µs).
The masker offsets in three test electrodes were decreased in 9 steps from +10 CL to -80 CL (masker offsets = +10, +5, 0, . An additional condition with the masker current level of 0 in other words, masker offset of minus probe current level (abbreviation -PCL), was added as a baseline level. The probe level was set to either T-ECAP (P1 probe level) or the current level that yielded 100 µV ECAP response amplitude (P2 probe level). The P2 probe level was determined from the AGF measurement. The P1 probe level was only used to investigate the facilitation effect since the current level of threshold is too low for recovery recordings. One extra measurement series with the masker level equal to LAPL, the probe level 10 CL lower than LAPL (P3 probe level) (Morsnowski et al., 2006; Botros and Psarros, 2010 ) and the MPI starting from 100 µs (11 MPIs) was recorded to investigate changes of the recovery function at a higher stimulus level. Therefore, P1 and P2 probe levels were used for the facilitation measurements and P2 and P3 probe levels were used for the recovery measurements.
The recording electrode was chosen to be two electrodes apical to the stimulation site and recordings were obtained at a probe repetition rate of 80 pulses per second (pps) to minimize adaptation effects. Previous studies have shown that for probe repetition rates up to approximately 200 pps, the ECAP amplitudes are captured with the complete recovery from the previous pulse (Rubinstein et al., 1999; Matsuoka et al., 2001; Hughes et al., 2012; Hughes and Laurello, 2017) . The ECAP amplifier gain was set to 50 dB and the number of averages was 50, because typically 50 to 100 sweeps are enough to get a reasonably noise-free ECAP response (Lai, 1999) . All measurements in this study were performed using the clinical CSEP software v.5.0 (Patrick et al., 2006) , and in order to have a control over recording parameters, a series definition (.csv) file was imported into the clinical CSEP software for each series of measurement.
Recovery and facilitation functions
The ECAP recovery was modeled by an exponential function consistent with other studies (Battmer et al., 2004; Morsnowski et al., 2006; Cohen, 2009; Botros and Psarros, 2010; Lee et al., 2012; He et al., 2017) . The aforementioned masker offsets in section 2.2 were used and the recovery function parameters were obtained by fitting the exponential function to data from the most intense masker (masker offset +10 CL) when the probe level was large enough (P2 and P3 probe levels) (Cohen, 2009; Botros and Psarros, 2010) to elicit a clear ECAP response. In this study, the ECAP recovery function for different masker offsets was modeled with the following exponential function:
where A represents the maximum ECAP amplitude in µV after a long enough MPI, r corresponds to the ECAP residual response at MPI equal to the absolute refractory period (ARP), T 0 is ARP and is the recovery function time constant.
For the largest masker offset in this study (+10 CL), the probe was completely masked and the partiallymasked probe response was approximately zero for MPI equal to ARP; this was checked and confirmed by visual inspection. However, for smaller masker offsets than +10 CL, there was residual response at ARP which was an indication of incomplete masking of the probe. Further decrease of masker offsets led to a larger residual response and a bigger r. Thus, r was added to the recovery function to consider the residual response at MPI equal to ARP and varies between 0 and 1. The recovery function for different masker offsets at the same probe level should converge to the maximum ECAP amplitude (A in Eq. 1) at large enough MPIs. Therefore, 1-r was applied to the recovery function to scale the function for different masker offsets. When r is equal to zero which would be the case for an intense masker, the recovery function is the same as in former studies (Battmer et al., 2004; Morsnowski et al., 2006; Cohen, 2009; Botros and Psarros, 2010; Lee et al., 2012; He et al., 2017) . To calculate r, the recovery function amplitude at the ARP was divided by the maximum recovery function amplitude.
In Eq. 1, is considered as a measure of the speed of recovery from the relative refractoriness (RRP) and T 0 is equal to the absolute refractory period (ARP) in µs. The ECAP response amplitude is obtained by the potential difference between N1 and P1 peaks and measured in microvolts. A represents the maximum ECAP amplitude in µV at a large MPI when the neurons are fully recovered (Botros and Psarros, 2010; He et al., 2017) . The parameters T 0 , and A were adjusted to data using the MATLAB 'Curve Fitting Toolbox' and finding the minimum residual sum of squares (Draper and Smith, 2014) . All three parameters were allowed to vary during curve fitting but were constrained to positive values ).
The facilitation effect was modeled by fitting a decaying exponential function (Cartee et al., 2000; Boulet, 2016) to data from masker offset of +10 CL and P2 probe level. It was shown previously that the facilitation effect in contrast to the recovery is not dependent on the probe level (Hey et al., 2017) . Therefore, the function was fitted to data from the P2 probe level and the goodness of fit for facilitation data with the P1 probe level was calculated afterwards. The facilitation has an overlap with the recovery function (Hey et al., 2017; Cohen, 2009) and when the facilitation effect is decreasing, the refractoriness starts to be a dominant effect. In order to model the facilitation effect for different masker offsets a shift (A×r) was added to the decaying exponential function. Therefore, the facilitation function for different masker offsets was modeled with the exponential function:
where F 0 is facilitation strength or maximum facilitation amplitude in µV and is the facilitation time constant. A and r are the same parameters as before and the MPI is changing from 13 µs to ARP. The parameters F 0 and were fit to data using the MATLAB 'Curve Fitting Toolbox' and finding the minimum residual sum of squares (Draper and Smith, 2014) and were constrained to positive values. Fig. 1 shows an example of reconstructed ECAP responses with the contributions of the recovery and the facilitation functions making use of the 'BC recording' and the P2 probe level; different masker offsets are shown with different colors. In this figure, median of recovery and facilitation parameters measured in 11 CI recipients who participated in the study were inserted into the fitted exponential functions. Adjustments were made for facilitation strengths of different masker offsets for better visualization. In Fig.1 
the T-ECAP
is 20 CL lower than the probe level which was used, therefore the maximum facilitation was obtained at -20 CL masker offset. This is consistent with the study of Hey et al. (2017) , which showed that the facilitation effect in the ECAP response is largest at masker levels near CI recipient's individual ECAP threshold. It is worth mentioning that in some cases the facilitation effect for the masker offset of +10 CL does not have small amplitudes at ARP (indicating that the facilitation function has a longer time constant) and there is a large overlap with the recovery function. This leads to a different shape of the contributions of the two phenomena, which will be discussed further in the Appendix.
[ Figure 1 about here.] 
Data Analysis
The 'BC recording' traces were stored in the clinical CSEP software and the offline processing of the traces were performed using MATLAB. A Wilcoxon rank sum test was used to investigate the effect of probe level on the ARP, the recovery and facilitation time constants and the facilitation strength. A nonparametric test was used because the sample size in this study was small and the recovery and facilitation time constants, the ARP and the facilitation strength do not follow a normal distribution (Morsnowski et al., 2006; Botros and Psarros, 2010) . Median values and quartiles were calculated and displayed. The Pearson correlation coefficient was used to test for correlation between the facilitation strengths and the AGF slopes. Goodness of fit for fitted functions was calculated by finding a coefficient of determination (R 2 or R-squared) with a closer value to 1 indicating a better fit.
Results

Influence of probe and masker stimulation levels on the recovery function
The recovery functions were measured at two probe stimulation levels (P2 and P3 probe levels) with the reference measurement at +10 CL masker offset and MPI of 300 µs. One CI subject (subject S2) was excluded for the comparison of the two probe levels because the P3 probe level was equal to the P2 probe level in all test electrodes and it was not possible to increase the probe stimulation level higher than the P2. An example of changing the recovery function with the probe stimulation level measured at electrode E12 of subject S9 is shown in Fig. 2 . The probe level is changed from P2 (blue curve) to P3 (red curve) while the masker offset kept constant at +10 CL.
[ Figure 2 about here.]
The T 0 and the recovery time constant are changing with the probe level in the fitted functions shown in Fig. 2 , with a smaller T 0 and a faster recovery for a larger probe level. This shows the importance of the probe stimulation level on recovery function parameters. There was a clear difference between recovery time constants obtained with the P2 probe level and recovery time constants obtained with the P3 probe level at three test electrodes (E6, E12 and E18). A nonparametric Wilcoxon rank sum test revealed that the difference was significant ( < 0.05) for all test electrodes independent of the electrode position along the cochlea. Therefore, there is a trend towards shorter recovery time constant with increasing probe level. However, the difference in absolute refractory periods (T 0 ) at two probe levels was only significant ( < 0.05) for electrode E12. The distributions of absolute refractory periods and recovery time constants at three test electrodes and two probe levels for 10 CI subjects are presented in Fig. 3 .
[ Figure 3 about here.]
The recovery functions at the P2 probe level were measured for 10 masker offsets. It was shown that the recovery function parameters for different masker offsets can be obtained by fitting the decaying exponential function to data from the most intense masker (+10 CL in this study) (Cohen, 2009) . r in Eq. 1 is the parameter which scales and shifts the fitted recovery curve of the most intense masker to model different masker offsets. An example of modeling the recovery functions for different masker offsets with the same function used for the +10 CL masker offset condition, obtained in subject S6 at electrode E6 is shown in Fig. 4 .
[ Figure 4 about here.]
The decaying exponential function was fitted to data by finding the minimum residual sum of squares and then the coefficient of determination was calculated for each masker offset curve to evaluate the scatter of the data points around the fitted function. As it is shown in Fig. 4 , the decaying exponential functions were fitted to data from +10 CL to -20 CL masker offsets and further decrease of the masker offsets leads to the unmasked probe response indicated by flat lines at 100 µV ECAP amplitude. However, this can vary among CI subjects and for small differences between the T-ECAP and the P2 probe level (e.g. subjects S3 and S8 in this study). The unmasked probe response, or in other words, the flat fitted lines to recovery data could be observed even at bigger masker offsets.
R-squared values closer to 1 indicate a better fit. Mean, standard deviation, maximum and minimum values of the R-squared of different masker offsets at the P2 probe level for all three test electrodes are presented in Table 2 . The R-squared was calculated for the decaying exponential functions excluding recovery functions with flat lines. Therefore, the number of stimulation sites to calculate mean, standard deviation, maximum and minimum values of the R-squared was varied for different masker offsets and is presented in the last row of Table 2 with the maximum number of 32 (11 CI recipients × 2 test electrodes (E12, E18) + 10 × 1 test electrode (E6)). Subject S2 was excluded for electrode E6 because the recovery function did not follow the typical decaying exponential function. This data will be discussed further in the Appendix. The masker offsets smaller than -20 CL are not presented in Table 2 because the fitted recovery functions for these masker offsets were flat lines as discussed above.
[ Table 2 about here.]
Influence of probe and masker stimulation levels on the facilitation function
Facilitation functions were measured at two probe stimulation levels (P1 and P2) with the reference measurement at +10 CL masker offset and the MPI of 300 µs. The ECAP responses at electrode E12 of subjects S2 and S3 and electrode E18 of subjects S2, S6, S10 and S11 with the P1 probe stimulation level were noisy and therefore were excluded. Thus, the maximum number of stimulation sites for the P1 probe level was 27 (11 CI × electrode E6 + 9 CI × electrode E12 + 7 CI × electrode E18) instead of 33 (11 CI × 3 test electrodes (E6, E12 and E18)).
The facilitation strength (F 0 ) and the facilitation time constant ( ) at two probe levels and three test electrodes were calculated from fitted decaying exponential function to data from +10 CL masker offset and the distributions of these parameters are presented in Fig. 5 . A nonparametric Wilcoxon rank sum test showed that there was no significant difference between the facilitation time constant and the facilitation strength obtained with the P1 probe level and the facilitation time constant and the facilitation strength obtained with the P2 probe level. Therefore, the facilitation function is not dependent on the probe level and the same set of parameters fitted to data with the P2 probe level could be used for the P1 probe level.
[ Figure 5 about here.]
Facilitation functions at P1 and P2 probe levels were measured with the same masker offsets as the recovery function at the P2 probe level. Facilitation parameters for different masker offsets can be obtained by fitting the decaying exponential function to data from +10 CL masker offset and applying a shift (A × r) to model different masker offsets with the same function used for the +10 CL masker offset condition. An example of modeling the facilitation functions for different masker offsets with the facilitation parameters fitted to data from +10 CL masker offset and the P2 probe level obtained in subject S6 (electrode E6) is shown in Fig. 6 . For this electrode of subject S6, the P2 probe level is around 20 CL higher than the T-ECAP; thus -20 CL masker offset has the largest facilitation effect which is shown with the yellow curve in Fig. 6 . Masker offsets of -80 CL and -PCL are not shown in the figure because the decaying exponential function was not a good fit to this data. Combining the recovery function in Fig. 4 and the facilitation function in Fig. 6 leads to the example reconstructed ECAP responses of Fig. 1 .
[ Figure 6 about here.]
As already mentioned, the facilitation does not show dependency on the probe intensity. Therefore, the fitted parameters obtained with the P2 probe level were used for the P1 probe level and the goodness of M A N U S C R I P T
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fit was calculated by finding coefficient of determinations for different masker offsets. Mean, standard deviation, maximum and minimum values of the R-squared of different masker offsets for two probe levels (P1 and P2) are presented in Table 3 . The number of stimulation sites is smaller than 27 for the P1 probe level and smaller than 33 for the P2 probe level if R-squared values were omitted. The masker offset of -PCL is not presented in Table 3 because of negative R-squared values which means that the fitted exponential function was worse than a horizontal line. Small R-squared values for some data points show that the decaying exponential function is not an appropriate fitting function for obtained data with these masker offsets.
[ Table 3 about here.]
Relation between facilitation strength and AGF slope
A general trend towards larger facilitation strengths (F 0 ) with increasing AGF slopes was observed. The correlation between the facilitation strength and the AGF slope at the P1 probe level was highly significant for electrode E6 (Pearson correlation coefficient = 0.9322; < 0.001) and was significant for electrode E12 ( = 0.8857; < 0.05) and electrode E18 ( = 0.7646; < 0.05). The correlation was also evident between the facilitation strength and the AGF slope at the P2 probe level. Highly significant Pearson correlations were observed for electrode E6 ( = 0.9256; < 0.001) and electrode E18 ( = 0.9480; < 0.001), as well as significant correlation for electrode E12 ( = 0.8278; < 0.05). We further examined the correlation in all three test electrodes at two probe levels and the correlation was highly significant ( < 0.001) for both probe levels. The Pearson correlation coefficient was = 0.8512 for the P1 probe level and = 0.8723 for the P2 probe level. The Pearson correlation coefficients and p values for three test electrodes and two probe levels (P1 and P2) are summarized in Table 4 and the scatter plots are shown in Fig. 7 . Data points in each scatter plot are from three test electrodes.
[ Table 4 
Discussion
In this study, ECAP responses in human CI recipients were recorded using MPIs of 13-6000 µs. A twopulse stimulation paradigm was used with a variation of masker and probe levels. The effect of probe stimulation level on absolute refractory period, recovery time constant, facilitation strength and facilitation time constant was investigated in 11 CI subjects at three test electrodes. In addition, it was possible to model recovery and facilitation phenomena for different masker offsets with the same function used for the +10 CL masker offset condition. This study was the first to model the facilitation effect in human CI users with a decaying exponential function.
Most of former studies recorded the recovery function in CI recipients at high probe stimulation levels i.e. 10 CL lower than LAPL Shpak et al., 2004; Morsnowski et al., 2006; Botros and Psarros, 2010; Kim et al., 2011; Lee et al., 2012) . Cohen (2009) obtained ECAP responses in 5 CI subjects at three probe levels and observed that the recovery time constant varied with the probe intensity in 2 subjects and did not change in the other 3 subjects. Battmer et al. (2004) reported changes of the recovery time constant with the probe stimulation level, however, only one CI recipient participated in the study. Therefore, the effect of probe stimulation level on recovery parameters was investigated in this study, which showed a significant effect of probe level on the recovery time constant. This is consistent with the previous studies and indicates the importance of measuring the recovery function at relatively high probe levels Shpak et al., 2004; Morsnowski et al., 2006; Botros and Psarros, 2010; Lee et al., 2012) .
Two CI subjects (S3 and S8) in this study had longer recovery time constants at the P2 probe level compared to the other participants. The P2 probe level was considered because recovery functions for all CI subjects were compared at equal ECAP amplitudes (100 µV). We further examined AGF recordings and observed that the AGF slopes at three test electrodes were steeper for these two subjects. Several studies have reported data showing that the AGF slope correlates with the neural survival (Smith and Simmons, 1983; Hall, 1990; Brown et al., 1990; Jeong et al., 2007) . In addition, it was shown that a larger M A N U S C R I P T
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9 neural population is associated with a slower ECAP recovery and provides equal ECAP amplitude with a smaller stimulus level (Botros and Psarros, 2010) . This is consistent with data recorded in this study and assuming higher neural density in subjects S3 and S8.
In the masker-probe paradigm, incomplete masking with a smaller masker leads to a residual response at ARP (Cohen, 2009) . Therefore, the smaller masker offsets had bigger residual responses at the ARP and this fact was considered in this study for the modeling of recovery and facilitation functions at different masker offsets with the same set of parameters. When the masker offset was very small, for instance -PCL, there was no masking and the output of the modified forward masking method was a flat line ( Fig. 1 and Fig. 4) .
ECAP responses at the P2 probe level in some CI subjects did not reach 100 µV amplitude in large MPIs and remained lower than this amplitude at 6000 µs. It was shown that very slow adaptation could happen during a series of NRT runs up to about 2100 s (Cohen, 2009 ) and each series of facilitation and recovery measurement for each probe level in this study took 489 s. In addition, accommodation which is considered as a reduction in the excitability of ANFs by subthreshold pulses could be the reason of this decrease in the ECAP amplitude. It was shown that accommodation occurs when there is a subthreshold response to the masker pulse, but this leads to the decrease of probability of firing to the probe pulse when the masker probe interval is so large (Sly et al., 2007; Cohen, 2009; Boulet et al., 2016) .
This study was the first to describe the facilitation effect with the decaying exponential function for different masker offsets and the goodness of fit was calculated. We observed that unlike the recovery function, the facilitation function was independent of the probe intensity and was stronger for the masker level around the T-ECAP. This is consistent with the study of Hey et al. (2017) . The facilitation amplitude correlated positively with the AGF slope which shows that CI subjects with higher neural density have larger facilitation responses. In this study, the median facilitation time constant found from the exponential fit was 137 µs, 117 µs and 127 µs for test electrodes E6, E12 and E18. This time constant is in the range which was reported by Cartee et al. (2000) . However, it is shorter than the time constant reported in other animal studies (Dynes, 1996; Boulet et al., 2016) . It is worth mentioning that we did observe longer facilitation time constants in one CI recipient in this study, which led to an overlap of facilitation and recovery functions and an unusual elevation in the ECAP response amplitude (Appendix). Further investigations should be conducted to explore the range of facilitation time constants and possible correlates with other parameters. It is also noted that the exact geometric locations of the selected test electrodes is outside the scope of this study, and represent general intracochlear locations, especially since the subjects had different electrode array models, and very likely different insertion depths and cochlea sizes.
Conclusions
In the present study, we investigated the influence of masker and probe levels on the recovery and the facilitation functions obtained from recording of ECAP responses in 11 CI recipients. A significant effect of the probe level on the recovery time constant was observed. However, it was shown that the facilitation time constant and amplitude were not probe intensity dependent. The facilitation strength was positively correlated with the AGF slope independent of the probe level and the electrode position along the cochlea and was stronger for the masker level at or around the T-ECAP.
It was possible to describe recovery and facilitation functions for different masker offsets with the same function used for the +10 CL masker offset. The calculated R-squared values showed the goodness of fit for the decaying exponential functions fitted to data. The facilitation effect obtained from CI recipients was modeled with the decaying exponential function. This effect together with other ANFs' neurophysiological characteristics will be used in a subsequent study on a bio-inspired sound coding strategy for cochlear implants.
ECAP recording at electrode E6 in subject S2 led to a different shape of the contributions of these two phenomena which is presented in Fig. A1 . As it is shown in the figure, the recovery function does not follow the typical decaying exponential function and there is an enhancement of response at the MPI around 1000 µs. This elevation of response amplitude exists up to -20 CL masker offset. Further decrease of the masker offset led to a disappearance of the response elevation.
[ Figure A1 about here.]
We further examined whether decreasing the probe stimulation level could reduce the elevation in the recovery function. Thus, the probe level was decreased in three steps while the masker offset was kept constant at +10 CL and only the MPIs larger than 400 µs (ARP of electrode E6) were considered. The probe stimulation level in Fig. A1 is 200 CL and three test probe levels were selected 195 CL, 190 CL and 180 CL. The recovery functions with these three probe levels as a function of MPI changing between 400 µs and 6000 µs are presented in Fig. A2 . Although the ECAP response amplitude became smaller for the probe level at 180 CL, the elevation was still present in the response and did not disappear.
[ Figure A2 about here.] This elevation in the recovery function was reported by Cohen (2009) and it was attributed to the facilitation effect. Further examination of the data showed that this subject had a very large facilitation time constant at electrode E6; 460 µs in comparison to 137 µs which is the median value of the facilitation time constant at this electrode. Therefore, the facilitation effect does not disappear completely when the recovery function starts, and these two phenomena have a larger overlap in comparison to the other CI subjects who participated in this study. By increasing the MPI beyond 1000 µs, the facilitation effect disappears, and the recovery function looks like the typical decaying exponential function again.
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Fig. 2.
Recovery functions with two probe stimulation levels obtained in subject S9 with the reference measurement at +10 CL masker offset and MPI of 300 µs. P2 probe level is shown in blue and P3 probe level is shown in red. Open symbols represent subject data and filled symbols are extrapolated ARPs. Solid lines display fitted functions and the ARPs are marked by vertical dashed lines. Fig. 3 . Distributions of absolute refractory period (left) and recovery time constant (right) at three test electrodes (E6, E12 and E18) and two probe levels (P2 and P3). 
